Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck's New Pricing Pledge Shows Style Over Substance

Jul 20 2018

• By Emily Hayes

Money Wave

Related Content

Janssen Emphasizes Average Net Price Decline As Transparency Momentum Builds In States

Mar 12 2018

Novartis Puts A Halt To Drug Price Increases While Awaiting More On Trump's Blueprint

Jul 18 2018

No More Nucs: Merck & Co. Cedes HCV Market To Gilead, AbbVie

Sep 29 2017

Lilly's Prices After Concessions Rise 6% In 2017, While Merck's Net Prices Decline

Apr 05 2018

Trump Drug Pricing Plan Includes Part D Surprises, Challenges PBM Business Model

May 12 2018

Big Pharma Voluntary List Price Reductions Doubtful, Sen. Warren Says

Jun 13 2018

J&J Stays Within Price Pledge, But Average Doesn't Tell The Whole Story, Analyst Says

Mar 27 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Trump Tries To Shame A Defiant Pfizer On Drug Pricing

Jul 10 2018

Related Companies

Merck & Co., Inc.

Johnson & Johnson

Gilead Sciences, Inc.

AbbVie Inc.

Eli Lilly and Company

Novartis AG

Pfizer Inc.

Additional Topics

Pricing Debate Pricing Strategies Policy Sales & Earnings Reimbursement BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.